An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 109 (2-3) , 85-92
- https://doi.org/10.1016/s0049-3848(03)00059-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatmentJournal of Clinical Pathology, 2001
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest, 2001
- Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia RegistryPediatric Research, 2000
- A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous ThromboembolismArchives of internal medicine (1960), 2000
- Analysis of Warfarin Therapy in Pediatric Patients: A Prospective Cohort Study of 319 PatientsBlood, 1999
- Book ReviewsClinical and Applied Thrombosis/hemostasis, 1999
- Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic ComplicationsThe Journal of Pediatrics, 1998
- The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In VitroThrombosis and Haemostasis, 1998
- Heparin Therapy in Pediatric Patients: A Prospective Cohort StudyPediatric Research, 1994
- Heparin clearance and ex vivo recovery in newborn piglets and adult pigsThrombosis Research, 1988